gentiopicroside has been researched along with Rheumatoid Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Mu, F; Wu, H; You, Q; Zhang, N | 1 |
| Gao, HQ; Ge, S; Wei, Y; Wu, C | 1 |
2 other study(ies) available for gentiopicroside and Rheumatoid Arthritis
| Article | Year |
|---|---|
Gentiopicrin exerts anti-rheumatic effect in human fibroblast-like synoviocytes via inhibition of p38MAPK/NF-κB pathway.
Topics: Arthritis, Rheumatoid; Cell Survival; Cells, Cultured; Fibroblasts; Humans; Imidazoles; Interleukin-1beta; Interleukin-6; Iridoid Glucosides; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Pyridines; RNA, Messenger; Signal Transduction; Sulfones; Synoviocytes; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2019 |
[Effect of swertiamarin, gentiopicrin and sweroside on cell apoptosis and expression of Bcl-2 in rheumatoid arthritis fibroblast-like synoviocytes].
Topics: Apoptosis; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Fibroblasts; Humans; Iridoid Glucosides; Molecular Docking Simulation; Proto-Oncogene Proteins c-bcl-2; Pyrones; Synoviocytes | 2021 |